Patricia Seymour


Managing Director, BioProcess Technology Group

Patricia Seymour is Managing Director, BioProcess Technology Group, BDO USA, LLP, where she is responsible for assisting clients in developing overall CMC (chemistry, manufacturing and controls) strategies for diverse product pipelines, developing and implementing supply-chain strategies, managing outsourced process development and manufacturing activities from drug substances through to distribution as well as steering clients through CMC quality and regulatory requirements and overall CMC operations, including project management. Prior to BDO, she was a Principal Consultant with BioProcess Technology Consultants, a biologics CMC consulting firm, which was acquired by BDO in 2019.

Overall, she has over 25 years of experience in the biotechnology industry. Her knowledge spans the development and commercialization spectrum, including biologics and small-molecule development, supply-chain strategy and operations, quality, regulatory and manufacturing, management, and operations leadership.

Prior to joining BioProcess Technology Consultants, Ms. Seymour was Senior Director, Global Investigational Supply Operations at Millennium Pharmaceuticals (now part of Takeda), where she worked with other senior leaders to develop and implement CMC strategies. She was previously Director of Business Development at Covance Biotechnology Services (now part of the Fujifilm Diosynth Biotechnologies), where her responsibilities included negotiating contact manufacturing projects. As Senior Director, Corporate Development at Collaborative BioAlliance, she was instrumental in launching the new contract manufacturing business unit. Before Collaborative, Ms. Seymour held research and development positions at ImmunoGen, the Dana Farber Cancer Institute, and Memorial-Sloan Kettering.